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Background
Aging and Angiogenesis
Aging is associated with an increased risk for development of coronary and peripheral artery
diseases [1]. The extent of ischemic damage and functional recovery in case of extensive
impairment of vascularization due to arterial obliteration in either circulatory system largely
depends on the development of new collateral blood vessels. Aging is also accompanied by
a steady decline in immune functions that include but are not limited to defects in signaling
pathways and altered cytokine (IFNγ, VEGF) expression [2–4]. Age-related impairment of
angiogenesis has been documented in many previous studies [5–9]. Deficiencies in multiple
components of ischemia-induced neovascularization including but not limited to inhibition
of EC proliferation and function [7,10–12], impaired expression of angiogenic growth
factors, such as VEGF, bFGF, TGF-β, and PDGF [7,13–15], were implied in delayed or
failed angiogenesis in adult tissue. In addition, some recent studies have also demonstrated
significant contribution of ischemia-induced inflammatory responses to delayed cutaneous
wound healing with age [16,17].
TNF, TNF Receptors, and Angiogenesis
Angiogenesis is accompanied by perivascular inflammation and monocyte/macrophage
accumulation [18]. Tumor necrosis factor alpha (TNF-α), a macrophage/monocyte-derived
pluripotent mediator, can function as an angiogenic factor in one system and as an anti-
angiogenic factor in another system [19–22]. These mutually exclusive TNF-α effects were
attributed to TNF-α concentration and duration of the exposure, that is, low concentrations
and short exposure is angiogenic, whereas high concentrations and prolonged exposure is
anti-angiogenic [23]. Interestingly, impaired TNF-α and other cytokine signaling in EC were
correlated with enhanced apoptotic response in cutaneous microvasculature in adult tissue
[24]. TNF-α has been reported to induce the expression of many immunologically relevant
and angiogenesis-related genes [25,26], through two different TNF-α receptors, TNF-αR1
(p55) and TNF-αR2 (p75) [27–29]. In ECs, TNF-α increases the expression of well-known
angiogenic factors VEGF, bFGF, IL-8 [26]; however, the role of two distinct TNF-α
receptors in mediating these responses is still unclear. Although the distribution of p55 is
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more widespread, p75 is present in greater amounts on endothelial and hematopoietic
lineage cells [30]. Because p55 is largely known to mediate cytotoxic effects of TNF-α,
whereas signaling through p75 is mostly implied in protective effects of TNF-α [31,32], and
because aging is associated with increased expression of p55 and decreased expression of
p75 in lymphocytes from aged humans [33] we hypothesize that TNF signaling via its
receptors may play significant and, perhaps, divergent effects in neovascularization, repair,
and regeneration in adult tissue after acute myocardial infarction (AMI).
Aging, TNF Signaling, and Post-ischemic Recovery
Numerous reports suggest that VEGF and bFGF are critical growth factors in therapeutic
angiogenesis [34–37]. Because treatment with TNF activates transcription factor NFκB and
NFκB is known to regulate, both, VEGF and bFGF expression [26,38], it is conceivable that
impairment in TNF signaling may affect adversely post-ischemic recovery. Hence, it is
possible that age-associated changes in TNF signaling may influence post-ischemic recovery
processes in several ways. First, decreases with age expression of TNFR2/p75 coupled with
post-ischemic increases in the systemic levels of TNF may favor apoptosis in adult
cardiomyocytes and resident ECs [39] through impaired p75-mediated anti-apoptotic
signaling via NFκB, subsequently leading to inhibition of angiogenesis. It is also
conceivable that in adult tissue with decreased p75 receptor expression in general [40]
unopposed signaling through p55 receptor increases predominantly pro-apoptotic cascade
via increase in FADD, TRADD, and FASDD [33,40]. Furthermore, it is also likely that
previously reported decrease in VEGF expression in adult cells [2–4] may be a direct
consequence of age-associated decrease in the expression/signaling via p75. In this case, not
apoptosis, but rather direct inhibition of TNF-mediated angiogenic signaling
(TNF→NFκB→VEGF, bFGF) could be responsible for failure of post-ischemic recovery
and regeneration in adult tissue. Potential scenario could be as follows: in young tissue intact
signaling through both p55 and p75 receptors assures proper NFκB activation, followed by
transcriptional activation of VEGF and bFGF and other TNF-induced NFκB-mediated pro-
angiogenic genes (i.e., IL-8), whereas in cells from adult donors with decreased p75 receptor
expression [33,40] signaling through p55 receptor alone is not sufficient for proper NFκB
activation [41] and regulation of transcription of pro-angiogenesis genes which, at least in
part, may be responsible for impaired angiogenic response in adult tissue [5–9]. Finally,
VEGF, which is an early angiogenic growth factor response to ischemia [42], has been
shown to mobilize BM-derived EPCs in murine models and in humans [43,44]. Hence, age-
associated decrease in TNF-induced NFκB-mediated VEGF expression may be due to, in
part, decreased p75 receptor expression, which may lead to subsequent decrease in
mobilization and/or recruitment of BM-derived EPCs to the ischemic areas [41], thereby
representing an additional mechanism of impaired repair, angiogenesis, and regeneration in
adult coronary tissue.
Results
Constitutive Expression of p75 Is Decreased in Human PB EPCs from Donors of
Increasing Age
We and others have previously reported that there is an inverse relationship between
increased age and decreased angiogenesis [5,7,8]. Interestingly, similar inverse relationship
between increased age and decreased expression of TNFR2/p75 has been reported, in
contrast to increased levels of TNFR1/p55 in lymphocytes from adult donors [33]. To
evaluate age-associated changes in TNFR1 and 2 levels in human ECs we measured p55 and
p75 mRNA expression levels (using ribonuclease protection assay) in human PB EPCs
isolated from donors of increasing age. There was no significant change in the levels of p55
expression in EPCs from elderly donors compared to more than 20 year younger adults (Fig.
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45.1a). In contrast, there was more than 55% (p<0.01) decrease in p75 mRNA levels in
EPCs from elderly donors vs. younger adults (Fig. 45.1b).
Post-AMI Survival and Functional Myocardial Recovery Is Impaired in Old p75KO Mice
It was reported previously that TNF receptor knockout (KO) mice reveal exacerbated
damage and altered NFκB activation after ischemic injury [45]. We hypothesized that
signaling through p75 may be essential in pro-survival signaling in adult tissue. To examine
whether age-associated decreases in p75 expression may contribute to the failure of post-
AMI recovery in adults we evaluated survival, cardiac function, angiogenesis, and recovery
in a series of experiments in murine model of acute myocardial infarction (AMI) [ligation of
the left anterior descending (LAD) coronary artery] in young and old p75KO and p55KO
mice and age-matched wild-type (WT) controls. Overall surgical mortality death (within 24
h post-surgery) was <4% and these animals were excluded from the study, because surgical
and anesthesia errors could not be ruled out as the cause of death. The rest of all the deaths
occurred within 1 week post-AMI, and although not all mice hearts that died within 7 days
were examined, of those that were examined (~75%), most showed evidence of cardiac
rapture in peri-infarct myocardium and some revealed pericarditis (data not shown). There
was significant age-associated increase in post-AMI mortality in old WT mice (12% vs.
45% in young vs. old WTs) (Fig. 45.2a). Not surprisingly, post-AMI mortality in young
p75KO mice was approaching the mortality in old WT mice (35% vs. 45% in young p75KO
vs. old WTs) (Fig. 45.2a), suggesting development of an aging phenotype in young p75KO
mice. Interestingly, more than half of the mice in old p75KO group (60%) died within 7
days post-AMI (Fig. 45.2a). In contrast, no post-AMI mortality was observed in young p55
mice and post-AMI mortality in old p55KO was only 10%, approximately the same as in
young WTs (Fig. 45.2a). These latter data strongly suggest that lack of signaling through
p55 appears to improve significantly post-AMI survival (better than in WT mice) in young
p55KO, as well as in old p55KO mice (recovery in old p55KOs was as good as in young
WTs).
For evaluation of infarct size and left ventricular (LV) dimensions transthoracic
echocardiography was performed before surgery (LAD ligation), 7 and 28 days after
surgery. We measured LV circumference in systole (LVs) and diastole (LVd) and these
values were used to calculate change in fractional area using the following formula: [% LV
FS=(LVd − LVs/LVd) × 100]. We also calculated infarct size in the same view by
measuring infarct segment length and dividing it by diastolic circumference (× 100). For
both, change in fractional area and infarct size, we measured all parameters three times and
mean of these values were used to make comparisons. Compared to young WT mice,
between days 7 and 28 post-AMI functional recovery, as measured by percent decrease in
left ventricular fractional shortening (%LV FS), was considerably worse in mice of old WT
and young p75KO mice (Fig. 45.2b). LV FS (%) was significantly worse on days 7 and 28
post-AMI in old p75KO mice compared to WT young (more than 20% decrease compared
(p<0.05) and WT old and p75KO young (more than 10% decrease, p<0.05) (Fig. 45.2b).
Our results strongly suggest that signaling through p75 may be a critical factor for the
processes of post-ischemic recovery in adult tissue. Moreover, although lack of signaling
through p55 reveals age-related decrease in LV FS in old vs. young p55KO mice (Fig.
45.2b), post-MI recovery of, both, young and old p55KO mice was significantly better
statistically than in, both, young and old WT and p75KO age-matched counterparts,
suggesting that signaling through p55 may be harmful for post-AMI recovery, as others have
also shown previously [46, 47]. Please note that because of severe age-associated deficiency
in old p75KO mice compared to very mild age-associated change in p55KOs in post-AMI
recovery from here on all our data will give comparisons between young and old WT and
p75KO mice only. Ischemia-induced inflammatory infiltrate is increased and longer-lasting
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in p75KO and decreased in p55KO mice post-AMI. To quantify post-AMI inflammatory
infiltrate we evaluated the expression of myeloperoxidase-1 (MPO-1), a neutrophil marker,
and CD-68, a glycoprotein normally expressed on macrophages, also known in mice as
macrosialin. Compared to WT mice, quantification of MPO-1 (+) cells showed ~ 313%
(p75KO) and 49% (p55KO) increases on day 7, and ~ 31% (p75KO) increase and 32%
(p55KO) decrease on day 14 post-AMI (p < 0.03 for all, data not shown). Compared to WT
mice, quantification of CD-68 (+) cells showed ~ 5% (p75KO) and 24% (p55KO) decreases
on day 7, and ~ 85% (p75KO) increase and 39% (p55KO) decrease on day 14 post-AMI (p
< 0.05 for all, data not shown), suggesting that in the absence of p75 signaling post-AMI
inflammatory responses are increased and longer lasting, whereas in the absence on p55
signaling inflammatory responses decreased and are of short duration.
Cardiac Troponin I (cTnI) Expression Is Increased in Infarct Border Zone in p75KO Mice
To evaluate the magnitude of myocardial infarction and ongoing myocardial injury, we
immunostained sections of infarct border-zone area with cardiac troponin I (cTnI), a marker
that has proven to correlate well with infarct size and ongoing myocardial injury when
measured in the serum [47] as well as in immunostained tissue [48]. Compared to normal
non-infarct tissue (Fig. 45.3a, upper panel), myocardial tissue expression level of cTnI on
day 7 post-AMI was significantly increased in infarct border zone of young p75KO and old
WT and p75KO mice (Fig. 45.3b, upper panel and lower left panel). cTnI expression levels
were the highest in old p75KO mice (Fig. 45.3b, lower right panel), suggesting that extent of
myocardial damage and ongoing myocardial injury is still in dynamics 7 days post-AMI in
both young and old p75KO mice.
Capillary Density Is Decreased in Infarct and Infarct Border Zone in Old WT and Young and
Old p75KO Mice
As a measure of collateral blood flow recovery after ischemia we evaluated capillary density
in myocardium of young and old WT and p75KO mice 28 days after AMI surgery.
Compared to young WT mice there was significant decrease in capillary density (first
column – green staining) and the number of functional vessels (second column – red
staining) in old WT mice in infarct and infarct border zone (Fig. 45.4a, b). Compared to both
young and old WT mice post-AMI capillary density (green staining) and number of
functional vessels (red staining) was further decreased in young as well as old p75KO mice
(Fig. 45.4c, d). These data suggest age-associated decrease in post-AMI capillary density
and patent/functional vessels in old WT mice and significantly greater deficiency in
collateral vessel development and decrease in functional capillary network in young and old
p75KOs.
Compared to Old WT Mice Post-AMI Functional Capillary Density Is Decreased in Old
p75KOs in Infarct Border Zone
We quantified the capillary density and the number of functional vessels in old WT vs. old
p75KO mice. To make sure that each and every endothelial cell is counted we used a Z-
stack mode of confocal microscope and took at least 10 focal images each 0.5 µm thick
(data not shown). We then used computer-assisted ImageJ (NIH software) to calculate the
intensity of green (all ECs) and red (functional capillaries) in infarct myocardium 7 and 28
days post-AMI. When we compared capillary density in BS1-lectin-stained samples there
was no significant difference between old WT and old p75KO mice (Fig. 45.5a). Between
days 7 and 28 in old WT mice there was a significant increase in the functional capillary
network (8.49±1.2 vs. 27.3±3.4, days 7 vs. day 28, respectively, p<0.001) (Fig. 45.5b),
suggesting development of collateral vessels in old WT mice. Compared to old WT mice,
the network of functional vessels in old p75KO mice was also not significantly different
between old WT and old p75KO mice on day 7 post-AMI (8.49±1.2 vs. 11.2±3.4, old WT
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vs. old p75KO, respectively, p=NS) (Fig. 45.5b). Interestingly, by day 28 there was
approximately threefold decrease in the functional capillary network in old p75KO mice
compared to old WT mice (10.9±0.7 vs. 27.3±3.4, respectively, p<0.001) (Fig. 45.5b),
strongly suggesting significant deficiency in development of collateral vessels in old p75KO
mice post-AMI.
Ischemia-Induced Apoptosis Is Increased in the Myocardium of Old p75KO Mice 28 Days
Post-AMI
To evaluate the apoptotic processes in infarct myocardium in young and old WT and p75KO
mice we immunostained sections of infarct border-zone area for TUNEL, a marker of
apoptosis, for BS1-lectin, a marker of ECs, and for TopRo3 to visualize nuclei. No apoptosis
was detectable in hearts of WT or p75KO mice before AMI surgery (Fig. 45.6a,
representative image of old p75KO heart). There were comparable increases in TUNEL (+)
apoptotic cells (Fig. 45.6b, c, left column, green staining), as well as comparable decreases
in BS1-lectin (+) cells (Fig. 45.6b, c, second column – red staining) on day 7 after AMI in
ischemic myocardium of WT and p75KO old mice. By day 28, compared to old WT mice,
p75KO old mice revealed extensive apoptosis in infarct area (Fig. 45.6d, e, left column –
green staining) and significant decrease in BS1-lectin staining (Fig. 45.6d, e, second column
– red staining), suggesting first that ischemia-induced myocardial apoptosis was augmented
and long-lasting in old p75KO mice and second that there was a significant deficiency in
functional collateral vessel development in old p75KO mice.
Expression of Several Angiogenic Growth and Stem Cell-Derived Factors and Their
Receptors Is Decreased in Peripheral Blood EPCs from Adult Donors
Finally, to determine if, in addition to decrease in expression of p75 in adult EPCs (Fig.
45.1b), there may be alterations in the expression of other genes that are involved in the
processes of post-ischemic recovery, such as post-natal angiogenesis and regulation of stem
and progenitor cell mobilization and recruitment to ischemic areas, we performed a series of
qRT-PCR studies. We collected peripheral blood (PB) from healthy young donors (age
32±14) and from older patients (age 67±7) of our Catheterization Laboratory that came for a
procedure. Please note that we did not need IRB approval for these studies because no
identification of patients was required (except the age) and blood would otherwise be
discarded. PB MNCs were isolated, then EPCs were grown on selective medium [41] and
after being 5 days in the culture PB EPCs were harvested and processed for qRT-PCR. The
expression of several potent angiogenic and pro-survival growth factors and cytokines such
as VEGF-A, ANG-2, TGF-β, HIF-1α, ET-1 (Fig. 45.7a-e), as well as expression of -stromal
cell-derived factors and their receptors, such as SDF-1α, CXCR4, and GCSFR (Fig. 45.7f-h)
was significantly decreased (2–5-fold) in EPCs from adult patients when compared to the
levels of these factors in the PB of normal volunteers. The significance of these finding may
or may not be directly related or dependent on signaling through TNFR2/p75 pathway; we
strongly believe that additional studies will be needed to elucidate the underlying molecular
mechanisms through TNFR2/p75 that may affect expression of these genes.
Several major conclusions arise as a result of our studies: (1) expression of p75/TNFR2 is
decreased in EPC from elderly donors; (2) loss of p75 expression impairs post-ischemic
recovery in infarct myocardium and increases post-AMI mortality; (3) signaling via p55
TNFR1 is harmful for ischemia-induced repair and regeneration processes and absence of
p55 receptor averts post-AMI mortality; (4) development of ischemia-induced functional
collateral vessel network is mediated, at least in part, via p75 TNFR2; (5) with advanced
age, signaling through p75 is required for collateral vessel development; (6) post-ischemic
apoptotic responses in infarct myocardium are augmented in the absence of p75 TNFR2; (7)
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expression of several angiogenic growth and stromal cell-derived factors and their receptors
is decreased in PB EPCs from adult donors.
Summary
Our data strongly suggest a critical role of TNF signaling via its receptors p55 and p75 in the
processes of post-ischemic recovery in adult tissue after myocardial infarction, that is,
signaling via TNFR1/p55 is deleterious and signaling via TNFR2/p75 is protective in repair
and regeneration processes in adult infarct myocardium. As illustrated in Diagram 45.1a and
b if occlusion of coronary artery is not resolved fast enough to prevent development of
myocardial infarction a cascade of pathological events and morphological changes in the
myocardium will develop beginning with necrosis, acute inflammation (heavy neutrophilic
infiltrate), apoptosis, followed by macrophage and mononuclear infiltration to initiate
fibrovascular response and granulation processes, which then may culminate in fibrosis and
scar formation. As depicted in our hypothetical Diagram 45.1c we propose that therapeutic
measures aimed toward either inhibition of signaling via TNFR1/p55 or overexpression of
TNFR2/p75 in infarct myocardium may decrease ischemia-induced inflammatory responses,
enhance neovascularization, and improve tissue regeneration, thereby minimizing
myocardial fibrosis and improving the poor recovery and development of severe ischemia-
induced damage in adult coronary diseases. Indeed, in support of our hypothesis several
other research groups, independently of our group, had reported that myocardial injection of
mesenchymal stem cells, genetically modified to overexpress TNFR2/p75, attenuates
inflammation and cardiac dysfunction following myocardial infarction [49]. Another group
had recently reported that signaling via both p55 and p75 is necessary to prevent reperfusion
injury after AMI during late preconditioning; however, they found that only signaling
through p75 is protective in non-preconditioned myocardium [50]. Because post-AMI
recovery is an “evolutionary” process and inflammatory cytokine levels, specifically TNF,
are significantly increased in infarct myocardium we strongly believe that further studies
aimed toward modulation of TNF receptor p55 and/or p75 expression at different
evolutionary stages of myocardial infarction may have important overarching implications
for (1) prevention of AMI-mediated myocardial injury, (2) augmentation of myocardial
repair and regeneration, and (3) improvement of therapeutic outcome of stem and progenitor
cell therapy for cardiovascular diseases.
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p75 TNFR2 expression is decreased in peripheral blood EPCs from elderly donors. Human
adult PB EPCs were collected and processed for evaluation of constitutive mRNA
expression of TNF receptors p55 and p75 by ribonuclease protection assay. We divided
(arbitrary) our donors into two groups: younger than 55 and older than 79 (n=5/age group).
(a) Densitometric analysis of p55 TNFR1 mRNA expression in human adult PB EPCs. RDU
–relative densitometric units. (b) Densitometric analysis of p75 TNFR2 mRNA expression
in human adult PB EPCs
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(a) Post-AMI mortality is increased in WT old and TNFR2/p75 young and old mice and
decreased in young and old TNFR1/p55 mice. Compared to WT young (6–8 weeks) mice
within 7 days there was approximately threefold increase in post-MI mortality in old (12–14
months) WT and young p75KO mice. Post-AMI mortality in old p75KO mice was fivefold
higher compared to young WT mice. No post-AMI mortality was observed in young p55
mice and post-AMI mortality in old p55KO was only 10%, approximately the same as in
young WTs. (b) Impaired signaling through TNFR2/p75 worsens age-related decrease in LV
FS in old p75KO mice, whereas signaling through TNFR1/p55 may be harmful for post-
AMI recovery in murine model of AMI. No significant difference in LV FS was observed
between mice of different genotypes before surgery. LV FS was significantly (p<0.05 day 7,
and p=NS day 28) decreased in old WT and young p75KO mice. The worst recovery was
observed in old p75KO mice. LV FS was significantly (p<0.05 day 7, and p=NS day 28)
decreased in old p55KO vs. young p55KO on day 28 post-AMI, suggesting some age-
associated impairment in post-MI recovery in old p55KO mice, although this degree of
recovery was as good as in young WT mice
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Cardiac troponin I (cTnI) expression is increased in infarct border zone in p75KO mice.
Representative confocal images of infarct border-zone myocardium of young and old WT
and p75KO mice 7 days after AMI were stained with anti-cTnI antibodies (red
fluorescence). cTnI expression was low in pre-surgery samples of all genotypes (p75KO old
tissue is shown) and was consistently and substantially higher in the post-AMI myocardium
of old WT and young and old p75KOs on day 7 post-AMI. Post-AMI hearts of at least three
animals per genotype/time point were examined and similar cTnI expression pattern, as
shown in these representative images, was observed in the tissues of young and old WT and
p75KOs. White dotted line divides border zone from infarct area and blue staining is
Topro-3 to identify nuclei
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Capillary density and the number of functional vessels are decreased in infarct and infarct
border zone in old WT and mice of p75KO genotype. Five minutes before harvesting hearts
mice were perfused with fluorescently labeled BS1-lectin (red) to identify functional/
perfused vessels. After harvesting and fixation heart sections were again stained with
fluorescently labeled BS1-lectin (green) to identify all vessels. (a and b) Representative
confocal images of infarct border-zone myocardium of young and old WT mice. Compared
to young WT mice capillary density and the number of functional vessels were consistently
and substantially lower in the myocardium of old WT 28 days post-AMI. (c and d)
Representative confocal images of infarct border-zone myocardium of young and old
p75KO mice. Compared to young and old WT mice capillary density and the number of
functional vessels were consistently and substantially lower in the myocardium of young
and old p75KO mice 28 days post-AMI. White dotted line divides border zone from infarct
area and blue staining is Topro-3 to identify nuclei. Post-AMI hearts of at least there
animals per genotype/time point were examined and similar pattern, as shown in these
representative images of randomly chosen areas of 0.09 mm2 of myocardial tissue, was
observed in the tissues of young and old WT and p75KO mice
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The number of functional vessels is decreased in infarct border zone in old p75KO mice. (a)
Quantification of all ECs. Insets are green BS1-lectin-positive cells; (b) quantification of
functional capillary network. Insets are red BS1-lectin perfused, hence patent vessels.
Compared to old WT mice capillary density and the number of functional vessels are
significantly threefold lower in old p75KO mice 28 days post-AMI. Post-AMI hearts of at
least three animals per genotype/time point were used to quantify the differences in capillary
network between old WT and old p75KO mice
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Ischemia-induced apoptosis is increased in the myocardium of old p75KO mice after AMI.
Representative confocal images of triple-stained heart muscle of old WT and old p75KO
mice to visualize TUNEL (+) cells. TUNEL (green) identifies apoptotic cells, BS1-lectin
(red) identifies functional endothelial cells, Topro3 (blue) visualizes nuclei. Representative
images show significant increase in the number of TUNEL (+) cells in old p75KO mice in
infarct area 28 days post-AMI. Post-AMI hearts of at least three animals per genotype/time
point were examined and similar pattern, as shown in these representative images of
randomly chosen areas of 0.09 mm2 of myocardial tissue, was observed in the hearts of old
WT and p75KO mice. White dotted line divides border zone from infarct area
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Expression of several angiogenic growth and stem cell-derived factors and their receptors is
decreased in peripheral blood EPCs from adult donors. qRT-PCR of PB EPCs from young
normal volunteers vs. adult CAT lab patients. (a–h) Expression of several angiogenic
growth and stromal cell factors and their receptors was decreased in PB EPCs obtained from
adult patients. All experiments were conducted in triplicate. The differences were considered
significant when p<0.05
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(a and b) Microscopic morphologic changes that evolve over time after AMI. Evolution of
microscopic morphologic changes after AMI: within first 24 h – myocardial fibers become
wavy, edema, hemorrhage, coagulation necrosis, and early neutrophilic infiltrate develops;
2–4 days – loss of nuclei, microscopic necrosis, heavy neutrophilic infiltrate, and dilation of
vessels develops; 5–14 days – macrophage and mononuclear infiltration and fibrovascular
responses begin followed by prominent granulation; 2–10 days – fibrosis with scarring
develops. (c) Hypothetical effect of modulation of TNF receptor expression on AMI
recovery outcome. Inhibition of p55 receptor in first hours and days after AMI may decrease
ischemia-induced acute inflammation and myocardial tissue damage, whereas p75 receptor
overexpression within days and weeks after AMI may enhance collateral vessel
development and myocardial regeneration
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